We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

OBN Awards Crown Synpromics ‘Best Emerging UK Synthetic Biotech Company’

News   Oct 09, 2017 | Original story from Synpromics

 
OBN Awards Crown Synpromics ‘Best Emerging UK Synthetic Biotech Company’

Image credit: Synpromics

 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine Trial Revived by WHO as Doubt Cast on Lancet, NEJM Studies

News

Testing of the malaria drug hydroxychloroquine as a treatment for COVID-19 has been restarted by the WHO after researchers raised concerns about the paper, published in The Lancet two weeks ago, that first suggested the drug was linked to reduced survival and a higher risk of heart-related side effects.

READ MORE

Primitive Genetic Alphabet Based on RNA and DNA

News

New research has suggested that early informational polymers might have been formed from DNA and RNA building blocks at the dawn of life.

READ MORE

Twin Study Finds Sensitivity Is Partly in Our Genes

News

The study compared pairs of identical and non-identical 17-year-old twins to see how strongly they were affected by positive or negative experiences – their "sensitivity" level.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE